U.S. Markets open in 7 hrs 13 mins

Acer Therapeutics (ACER) Shares March Higher, Can It Continue?

Zacks Equity Research
Mutual Fund Report for TRMCX

Investors certainly have to be happy with Acer Therapeutics Inc. ACER and its short term performance. After all, the stock has jumped by 30.9% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for ACER?

While we can never know for sure, it is pretty encouraging that estimates for ACER have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #2 (Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Opexa Therapeutics, Inc. (ACER) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research